{
  "metadata": {
    "config": {
      "backend": {
        "_target_": "cotlab.backends.VLLMBackend",
        "tensor_parallel_size": 1,
        "dtype": "bfloat16",
        "trust_remote_code": true,
        "max_model_len": 4096
      },
      "model": {
        "name": "google/medgemma-27b-text-it",
        "variant": "27b",
        "max_new_tokens": 1024,
        "temperature": 0.7,
        "top_p": 0.9,
        "safe_name": "medgemma_27b"
      },
      "prompt": {
        "_target_": "cotlab.prompts.OncologyPromptStrategy",
        "name": "oncology",
        "contrarian": false,
        "few_shot": true,
        "answer_first": false,
        "output_format": "json"
      },
      "dataset": {
        "_target_": "cotlab.datasets.OncologyDataset",
        "name": "oncology",
        "path": "data/oncology.json"
      },
      "experiment": {
        "_target_": "cotlab.experiments.RadiologyExperiment",
        "name": "radiology",
        "description": "Pathological fracture detection from radiology reports",
        "num_samples": -1
      },
      "seed": 42,
      "verbose": true,
      "dry_run": false
    },
    "start_time": "2026-01-10T19:43:07.137598"
  },
  "experiment": "radiology",
  "model": "google/medgemma-27b-text-it",
  "prompt_strategy": "oncology",
  "metrics": {
    "correct": 100,
    "incorrect": 0,
    "true_positives": 50,
    "true_negatives": 50,
    "false_positives": 0,
    "false_negatives": 0,
    "parse_errors": 0,
    "accuracy": 1.0,
    "parse_error_rate": 0.0,
    "precision": 1.0,
    "recall": 1.0,
    "f1": 1.0
  },
  "raw_outputs": [
    {
      "sample_idx": 0,
      "input": "02/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"Clinical improvement noted\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normalized blood counts and clinical improvement, indicating no current abnormal or malignant findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normalized blood counts and clinical improvement, indicating no current abnormal or malignant findings.",
      "findings": [
        "Resolved febrile illness",
        "Blood counts normalized",
        "No organomegaly",
        "Clinical improvement noted",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 0,
      "timestamp": "2026-01-10T19:44:18.275036"
    },
    {
      "sample_idx": 1,
      "input": "26/10/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly describes a posterior fossa mass with enhancement, restricted diffusion, and confirms high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes a posterior fossa mass with enhancement, restricted diffusion, and confirms high-grade medulloblastoma on histology, indicating malignancy.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 1,
      "timestamp": "2026-01-10T19:44:18.275063"
    },
    {
      "sample_idx": 2,
      "input": "03/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\"],\n        \"rationale\": \"The report identifies reactive lymphadenopathy, a benign finding. It explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies reactive lymphadenopathy, a benign finding. It explicitly states 'No malignancy identified'.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up"
      ],
      "fracture_mentioned": null,
      "idx": 2,
      "timestamp": "2026-01-10T19:44:18.275077"
    },
    {
      "sample_idx": 3,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy with mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"The report explicitly identifies abdominal lymphadenopathy and confirms Burkitt lymphoma via biopsy, which is a malignancy. High LDH levels are also noted, often associated with lymphoma.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies abdominal lymphadenopathy and confirms Burkitt lymphoma via biopsy, which is a malignancy. High LDH levels are also noted, often associated with lymphoma.",
      "findings": [
        "abdominal lymphadenopathy with mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "High LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 3,
      "timestamp": "2026-01-10T19:44:18.275091"
    },
    {
      "sample_idx": 4,
      "input": "04/05/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 04/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 4,
      "timestamp": "2026-01-10T19:44:18.275104"
    },
    {
      "sample_idx": 5,
      "input": "17/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 17/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is explicitly stated as secondary to a viral infection and not malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is explicitly stated as secondary to a viral infection and not malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection"
      ],
      "fracture_mentioned": null,
      "idx": 5,
      "timestamp": "2026-01-10T19:44:18.275116"
    },
    {
      "sample_idx": 6,
      "input": "11/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with the clinical suspicion and diagnosis of Neuroblastoma, a malignant tumour. The staging as Stage III disease further confirms malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with the clinical suspicion and diagnosis of Neuroblastoma, a malignant tumour. The staging as Stage III disease further confirms malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 6,
      "timestamp": "2026-01-10T19:44:18.275132"
    },
    {
      "sample_idx": 7,
      "input": "21/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings on chest radiograph, including clear lung fields, no mediastinal mass, and normal heart size.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings on chest radiograph, including clear lung fields, no mediastinal mass, and normal heart size.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 7,
      "timestamp": "2026-01-10T19:44:18.275155"
    },
    {
      "sample_idx": 8,
      "input": "08/02/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states normal CBC values, absence of blast cells, and explicitly concludes 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states normal CBC values, absence of blast cells, and explicitly concludes 'No malignancy identified'.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 8,
      "timestamp": "2026-01-10T19:44:18.275168"
    },
    {
      "sample_idx": 9,
      "input": "25/04/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly describes a large left renal mass identified as a Wilms Tumor, which is a type of kidney cancer, and confirms its stage and histology, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes a large left renal mass identified as a Wilms Tumor, which is a type of kidney cancer, and confirms its stage and histology, indicating malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 9,
      "timestamp": "2026-01-10T19:44:18.275181"
    },
    {
      "sample_idx": 10,
      "input": "26/12/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy with bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly identifies mediastinal lymphadenopathy, FDG-avid nodes, and diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies mediastinal lymphadenopathy, FDG-avid nodes, and diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, confirming malignancy.",
      "findings": [
        "mediastinal lymphadenopathy with bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 10,
      "timestamp": "2026-01-10T19:44:18.275193"
    },
    {
      "sample_idx": 11,
      "input": "18/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 18/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications and MIBG avidity, along with elevated urinary catecholamines. These findings, combined with the clinical suspicion and diagnosis of Neuroblastoma, indicate malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large suprarenal mass with calcifications and MIBG avidity, along with elevated urinary catecholamines. These findings, combined with the clinical suspicion and diagnosis of Neuroblastoma, indicate malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 11,
      "timestamp": "2026-01-10T19:44:18.275208"
    },
    {
      "sample_idx": 12,
      "input": "15/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 15/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"Hepatoblastoma\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report explicitly identifies a large heterogeneous hepatic mass and diagnoses Hepatoblastoma, a malignant liver tumor, with a specific staging (PRETEXT stage II).\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a large heterogeneous hepatic mass and diagnoses Hepatoblastoma, a malignant liver tumor, with a specific staging (PRETEXT stage II).",
      "findings": [
        "large heterogeneous hepatic mass",
        "Hepatoblastoma",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 12,
      "timestamp": "2026-01-10T19:44:18.275219"
    },
    {
      "sample_idx": 13,
      "input": "26/02/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Langerhans Cell Histiocytosis.\n\nFrom clinical notes: Langerhans Cell Histiocytosis. Paediatric oncology assessment.\n\nFindings: multiple lytic skull lesions with soft tissue component. CD1a and Langerin positive. Multisystem disease. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\", \"Multisystem disease\"],\n        \"rationale\": \"The report describes multiple lytic skull lesions with soft tissue components, which are abnormal findings. The positive CD1a and Langerin markers, along with the description of multisystem disease, are characteristic features of Langerhans Cell Histiocytosis, a type of malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes multiple lytic skull lesions with soft tissue components, which are abnormal findings. The positive CD1a and Langerin markers, along with the description of multisystem disease, are characteristic features of Langerhans Cell Histiocytosis, a type of malignancy.",
      "findings": [
        "multiple lytic skull lesions with soft tissue component",
        "CD1a and Langerin positive",
        "Multisystem disease"
      ],
      "fracture_mentioned": null,
      "idx": 13,
      "timestamp": "2026-01-10T19:44:18.275233"
    },
    {
      "sample_idx": 14,
      "input": "08/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 08/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are abnormal findings but explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are abnormal findings but explicitly states 'No malignancy identified'.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 14,
      "timestamp": "2026-01-10T19:44:18.275245"
    },
    {
      "sample_idx": 15,
      "input": "14/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 14/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report explicitly identifies a high percentage of myeloblasts in the bone marrow and a specific chromosomal translocation (t(8;21)), both strongly indicative of Acute Myeloid Leukemia, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a high percentage of myeloblasts in the bone marrow and a specific chromosomal translocation (t(8;21)), both strongly indicative of Acute Myeloid Leukemia, confirming malignancy.",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 15,
      "timestamp": "2026-01-10T19:44:18.275257"
    },
    {
      "sample_idx": 16,
      "input": "07/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 07/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies a parameningeal mass with intracranial extension and confirms the diagnosis of Embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a parameningeal mass with intracranial extension and confirms the diagnosis of Embryonal rhabdomyosarcoma on biopsy, indicating malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 16,
      "timestamp": "2026-01-10T19:44:18.275269"
    },
    {
      "sample_idx": 17,
      "input": "06/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings on the chest radiograph.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings on the chest radiograph.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 17,
      "timestamp": "2026-01-10T19:44:18.275280"
    },
    {
      "sample_idx": 18,
      "input": "23/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 23/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement, hydrocephalus, and restricted diffusion. Histology confirms a high-grade medulloblastoma, which is a malignant brain tumor.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a posterior fossa mass with enhancement, hydrocephalus, and restricted diffusion. Histology confirms a high-grade medulloblastoma, which is a malignant brain tumor.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 18,
      "timestamp": "2026-01-10T19:44:18.275292"
    },
    {
      "sample_idx": 19,
      "input": "09/07/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"The report explicitly identifies a large suprarenal mass with characteristics (heterogeneous, calcifications, MIBG avidity) and associated findings (elevated urinary catecholamines) consistent with Neuroblastoma, which is a malignancy. The report also explicitly states the clinical suspicion and diagnosis of Neuroblastoma and assigns a stage (Stage III), indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a large suprarenal mass with characteristics (heterogeneous, calcifications, MIBG avidity) and associated findings (elevated urinary catecholamines) consistent with Neuroblastoma, which is a malignancy. The report also explicitly states the clinical suspicion and diagnosis of Neuroblastoma and assigns a stage (Stage III), indicating malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 19,
      "timestamp": "2026-01-10T19:44:18.275309"
    },
    {
      "sample_idx": 20,
      "input": "18/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly identifies a 'large heterogeneous left renal mass with pseudocapsule' and diagnoses 'Wilms Tumor', which is a type of kidney cancer, confirming malignancy. The biopsy showing 'Favorable histology' and staging as 'Stage II' further support this diagnosis.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a 'large heterogeneous left renal mass with pseudocapsule' and diagnoses 'Wilms Tumor', which is a type of kidney cancer, confirming malignancy. The biopsy showing 'Favorable histology' and staging as 'Stage II' further support this diagnosis.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 20,
      "timestamp": "2026-01-10T19:44:18.275323"
    },
    {
      "sample_idx": 21,
      "input": "13/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 13/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal for age, with no mass lesions or abnormal enhancement. It explicitly concludes 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the brain MRI is normal for age, with no mass lesions or abnormal enhancement. It explicitly concludes 'No malignancy identified'.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 21,
      "timestamp": "2026-01-10T19:44:18.275335"
    },
    {
      "sample_idx": 22,
      "input": "18/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly identifies a large heterogeneous left renal mass and diagnoses it as a Wilms Tumor, which is a type of kidney cancer. The biopsy confirms favorable histology, and it is staged as Stage II, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a large heterogeneous left renal mass and diagnoses it as a Wilms Tumor, which is a type of kidney cancer. The biopsy confirms favorable histology, and it is staged as Stage II, indicating malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 22,
      "timestamp": "2026-01-10T19:44:18.275349"
    },
    {
      "sample_idx": 23,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'Normal brain MRI for age', 'No mass lesion', 'No abnormal enhancement', and directly concludes 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'Normal brain MRI for age', 'No mass lesion', 'No abnormal enhancement', and directly concludes 'No malignancy identified'.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 23,
      "timestamp": "2026-01-10T19:44:18.275360"
    },
    {
      "sample_idx": 24,
      "input": "16/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings on the brain MRI.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings on the brain MRI.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 24,
      "timestamp": "2026-01-10T19:44:18.275372"
    },
    {
      "sample_idx": 25,
      "input": "16/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"Onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes findings characteristic of a malignant bone tumor, including permeative bone destruction, a large soft tissue mass, and an onion-skin periosteal reaction. The presence of an EWSR1 fusion gene is specific for Ewing Sarcoma, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes findings characteristic of a malignant bone tumor, including permeative bone destruction, a large soft tissue mass, and an onion-skin periosteal reaction. The presence of an EWSR1 fusion gene is specific for Ewing Sarcoma, confirming malignancy.",
      "findings": [
        "permeative bone destruction",
        "large soft tissue mass",
        "Onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 25,
      "timestamp": "2026-01-10T19:44:18.275386"
    },
    {
      "sample_idx": 26,
      "input": "13/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 13/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"The report explicitly identifies abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and confirms Burkitt lymphoma via biopsy, which is a malignancy. High LDH levels are also noted.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and confirms Burkitt lymphoma via biopsy, which is a malignancy. High LDH levels are also noted.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "High LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 26,
      "timestamp": "2026-01-10T19:44:18.275399"
    },
    {
      "sample_idx": 27,
      "input": "25/06/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"Bone density normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes the findings as a 'normal process' with no pathological features.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes the findings as a 'normal process' with no pathological features.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "Bone density normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 27,
      "timestamp": "2026-01-10T19:44:18.275410"
    },
    {
      "sample_idx": 28,
      "input": "01/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 01/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified and notes the resolution of a benign bone cyst with no aggressive features.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified and notes the resolution of a benign bone cyst with no aggressive features.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 28,
      "timestamp": "2026-01-10T19:44:18.275421"
    },
    {
      "sample_idx": 29,
      "input": "04/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large heterogeneous suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and classifies the disease as Stage III. These findings are consistent with the suspected diagnosis of Neuroblastoma, a malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large heterogeneous suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and classifies the disease as Stage III. These findings are consistent with the suspected diagnosis of Neuroblastoma, a malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 29,
      "timestamp": "2026-01-10T19:44:18.275434"
    },
    {
      "sample_idx": 30,
      "input": "15/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 15/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement\", \"hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly identifies a posterior fossa mass with enhancement, hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a posterior fossa mass with enhancement, hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma on histology, indicating malignancy.",
      "findings": [
        "posterior fossa mass with enhancement",
        "hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 30,
      "timestamp": "2026-01-10T19:44:18.275447"
    },
    {
      "sample_idx": 31,
      "input": "02/04/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'Normal chest radiograph', 'Clear lung fields', 'No mediastinal mass', and 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'Normal chest radiograph', 'Clear lung fields', 'No mediastinal mass', and 'No malignancy identified'.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 31,
      "timestamp": "2026-01-10T19:44:18.275458"
    },
    {
      "sample_idx": 32,
      "input": "04/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"The report explicitly identifies a sacrococcygeal mass with solid and cystic components, elevated tumor markers (AFP and beta-hCG), and the presence of yolk sac tumor elements, which is a type of malignant germ cell tumor.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a sacrococcygeal mass with solid and cystic components, elevated tumor markers (AFP and beta-hCG), and the presence of yolk sac tumor elements, which is a type of malignant germ cell tumor.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 32,
      "timestamp": "2026-01-10T19:44:18.275471"
    },
    {
      "sample_idx": 33,
      "input": "24/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and specifically diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, which is a malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and specifically diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, which is a malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 33,
      "timestamp": "2026-01-10T19:44:18.275484"
    },
    {
      "sample_idx": 34,
      "input": "07/03/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 07/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states normal CBC, absence of blast cells, and no malignancy identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states normal CBC, absence of blast cells, and no malignancy identified.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 34,
      "timestamp": "2026-01-10T19:44:18.275494"
    },
    {
      "sample_idx": 35,
      "input": "04/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\"],\n        \"rationale\": \"The report identifies a benign soft tissue mass confirmed as a lipoma, which is not a malignancy. The report explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies a benign soft tissue mass confirmed as a lipoma, which is not a malignancy. The report explicitly states 'No malignancy identified'.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement"
      ],
      "fracture_mentioned": null,
      "idx": 35,
      "timestamp": "2026-01-10T19:44:18.275506"
    },
    {
      "sample_idx": 36,
      "input": "04/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings on the chest radiograph.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings on the chest radiograph.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 36,
      "timestamp": "2026-01-10T19:44:18.275517"
    },
    {
      "sample_idx": 37,
      "input": "02/04/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"Suspected Osteosarcoma\", \"Osteosarcoma\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. The clinical notes explicitly mention suspicion and diagnosis of osteosarcoma, a malignant bone tumor.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. The clinical notes explicitly mention suspicion and diagnosis of osteosarcoma, a malignant bone tumor.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "Suspected Osteosarcoma",
        "Osteosarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 37,
      "timestamp": "2026-01-10T19:44:18.275531"
    },
    {
      "sample_idx": 38,
      "input": "05/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 05/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"suspected Osteosarcoma\", \"Osteosarcoma\"],\n        \"rationale\": \"The report describes a destructive lesion in the femur with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. The clinical suspicion and diagnosis mentioned in the report strongly indicate malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the femur with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. The clinical suspicion and diagnosis mentioned in the report strongly indicate malignancy.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "suspected Osteosarcoma",
        "Osteosarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 38,
      "timestamp": "2026-01-10T19:44:18.275544"
    },
    {
      "sample_idx": 39,
      "input": "01/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 01/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\"],\n        \"rationale\": \"The report describes abnormal findings related to a recent viral infection (post-viral lymphocytosis, resolving atypical lymphocytes), but explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes abnormal findings related to a recent viral infection (post-viral lymphocytosis, resolving atypical lymphocytes), but explicitly states 'No malignancy identified'.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving"
      ],
      "fracture_mentioned": null,
      "idx": 39,
      "timestamp": "2026-01-10T19:44:18.275555"
    },
    {
      "sample_idx": 40,
      "input": "26/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly identifies a 'large heterogeneous left renal mass' diagnosed as 'Wilms Tumor' with 'Favorable histology' and staging, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a 'large heterogeneous left renal mass' diagnosed as 'Wilms Tumor' with 'Favorable histology' and staging, indicating malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 40,
      "timestamp": "2026-01-10T19:44:18.275567"
    },
    {
      "sample_idx": 41,
      "input": "18/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly identifies mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, which are indicative of malignancy. The report also explicitly states the diagnosis as Classical Hodgkin, nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, which are indicative of malignancy. The report also explicitly states the diagnosis as Classical Hodgkin, nodular sclerosing type, confirming malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 41,
      "timestamp": "2026-01-10T19:44:18.275581"
    },
    {
      "sample_idx": 42,
      "input": "20/04/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 20/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report identifies abnormal findings related to a viral infection (post-viral lymphocytosis, atypical lymphocytes, positive Monospot, confirmed EBV). However, the report explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies abnormal findings related to a viral infection (post-viral lymphocytosis, atypical lymphocytes, positive Monospot, confirmed EBV). However, the report explicitly states 'No malignancy identified'.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 42,
      "timestamp": "2026-01-10T19:44:18.275594"
    },
    {
      "sample_idx": 43,
      "input": "20/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 20/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings on the brain MRI.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings on the brain MRI.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 43,
      "timestamp": "2026-01-10T19:44:18.275604"
    },
    {
      "sample_idx": 44,
      "input": "22/11/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 22/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"Onion-skin periosteal reaction\", \"EWSR1 fusion positive\", \"Suspected Ewing Sarcoma\", \"Ewing Sarcoma\"],\n        \"rationale\": \"The report describes permeative bone destruction, a large soft tissue mass, and an onion-skin periosteal reaction in the femur, which are characteristic imaging findings of Ewing Sarcoma. Additionally, the EWSR1 fusion positivity is a specific genetic marker for Ewing Sarcoma. The clinical suspicion and diagnosis of Ewing Sarcoma confirm malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes permeative bone destruction, a large soft tissue mass, and an onion-skin periosteal reaction in the femur, which are characteristic imaging findings of Ewing Sarcoma. Additionally, the EWSR1 fusion positivity is a specific genetic marker for Ewing Sarcoma. The clinical suspicion and diagnosis of Ewing Sarcoma confirm malignancy.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "Onion-skin periosteal reaction",
        "EWSR1 fusion positive",
        "Suspected Ewing Sarcoma",
        "Ewing Sarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 44,
      "timestamp": "2026-01-10T19:44:18.275620"
    },
    {
      "sample_idx": 45,
      "input": "06/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states a normal brain MRI for age, absence of mass lesions or abnormal enhancement, and directly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states a normal brain MRI for age, absence of mass lesions or abnormal enhancement, and directly states 'No malignancy identified'.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 45,
      "timestamp": "2026-01-10T19:44:18.275631"
    },
    {
      "sample_idx": 46,
      "input": "24/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\"],\n        \"rationale\": \"The report identifies physiological splenomegaly as an abnormal finding but explicitly states it is benign and no malignancy was identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies physiological splenomegaly as an abnormal finding but explicitly states it is benign and no malignancy was identified.",
      "findings": [
        "Physiological splenomegaly for age"
      ],
      "fracture_mentioned": null,
      "idx": 46,
      "timestamp": "2026-01-10T19:44:18.275641"
    },
    {
      "sample_idx": 47,
      "input": "01/02/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 01/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\"],\n        \"rationale\": \"The report explicitly describes reactive lymphadenopathy, which is a benign finding. It also notes decreasing node size and explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly describes reactive lymphadenopathy, which is a benign finding. It also notes decreasing node size and explicitly states 'No malignancy identified'.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up"
      ],
      "fracture_mentioned": null,
      "idx": 47,
      "timestamp": "2026-01-10T19:44:18.275653"
    },
    {
      "sample_idx": 48,
      "input": "03/10/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"suspected osteosarcoma\", \"osteosarcoma\"],\n        \"rationale\": \"The report describes a destructive bone lesion with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. Osteosarcoma is explicitly suspected and mentioned in the clinical notes.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive bone lesion with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. Osteosarcoma is explicitly suspected and mentioned in the clinical notes.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "suspected osteosarcoma",
        "osteosarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 48,
      "timestamp": "2026-01-10T19:44:18.275666"
    },
    {
      "sample_idx": 49,
      "input": "05/08/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\"],\n        \"rationale\": \"The report identifies reactive lymphadenopathy, which is explicitly stated as secondary to a viral infection and not malignancy. The decreasing node size further supports a benign process.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies reactive lymphadenopathy, which is explicitly stated as secondary to a viral infection and not malignancy. The decreasing node size further supports a benign process.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up"
      ],
      "fracture_mentioned": null,
      "idx": 49,
      "timestamp": "2026-01-10T19:44:18.275678"
    },
    {
      "sample_idx": 50,
      "input": "02/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings on chest radiograph.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings on chest radiograph.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 50,
      "timestamp": "2026-01-10T19:44:18.275689"
    },
    {
      "sample_idx": 51,
      "input": "26/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes the finding as a 'Benign soft tissue mass - lipoma confirmed'. There are no findings suggestive of malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes the finding as a 'Benign soft tissue mass - lipoma confirmed'. There are no findings suggestive of malignancy.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 51,
      "timestamp": "2026-01-10T19:44:18.275701"
    },
    {
      "sample_idx": 52,
      "input": "25/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 25/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly identifies a large heterogeneous left renal mass, diagnosed as Wilms Tumor based on biopsy with favorable histology and staged as Stage II, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a large heterogeneous left renal mass, diagnosed as Wilms Tumor based on biopsy with favorable histology and staged as Stage II, confirming malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 52,
      "timestamp": "2026-01-10T19:44:18.275713"
    },
    {
      "sample_idx": 53,
      "input": "05/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is an abnormal finding but explicitly states it is secondary to a viral infection and not malignancy. The report explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is an abnormal finding but explicitly states it is secondary to a viral infection and not malignancy. The report explicitly states 'No malignancy identified'.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 53,
      "timestamp": "2026-01-10T19:44:18.275726"
    },
    {
      "sample_idx": 54,
      "input": "23/03/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 23/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Hepatoblastoma\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report explicitly identifies a 'large heterogeneous hepatic mass', 'elevated AFP', and diagnoses 'Hepatoblastoma' with a 'Fetal histology subtype' and 'PRETEXT stage II', confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a 'large heterogeneous hepatic mass', 'elevated AFP', and diagnoses 'Hepatoblastoma' with a 'Fetal histology subtype' and 'PRETEXT stage II', confirming malignancy.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Hepatoblastoma",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 54,
      "timestamp": "2026-01-10T19:44:18.275738"
    },
    {
      "sample_idx": 55,
      "input": "31/08/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 31/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'Normal chest radiograph', 'Clear lung fields', 'No mediastinal mass', 'Heart size normal', and directly concludes 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'Normal chest radiograph', 'Clear lung fields', 'No mediastinal mass', 'Heart size normal', and directly concludes 'No malignancy identified'.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 55,
      "timestamp": "2026-01-10T19:44:18.275750"
    },
    {
      "sample_idx": 56,
      "input": "26/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is an abnormal finding but explicitly states it is secondary to a viral infection and not malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is an abnormal finding but explicitly states it is secondary to a viral infection and not malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection"
      ],
      "fracture_mentioned": null,
      "idx": 56,
      "timestamp": "2026-01-10T19:44:18.275761"
    },
    {
      "sample_idx": 57,
      "input": "24/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"The report explicitly identifies a sacrococcygeal mass with solid and cystic components, elevated tumor markers (AFP and beta-hCG), and the presence of yolk sac tumor elements, which are indicative of malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a sacrococcygeal mass with solid and cystic components, elevated tumor markers (AFP and beta-hCG), and the presence of yolk sac tumor elements, which are indicative of malignancy.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 57,
      "timestamp": "2026-01-10T19:44:18.275774"
    },
    {
      "sample_idx": 58,
      "input": "01/01/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 01/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"The report explicitly describes a sacrococcygeal mass with solid and cystic components, elevated tumor markers (AFP and beta-hCG), and the presence of yolk sac tumor elements, which are indicative of a malignant germ cell tumor.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes a sacrococcygeal mass with solid and cystic components, elevated tumor markers (AFP and beta-hCG), and the presence of yolk sac tumor elements, which are indicative of a malignant germ cell tumor.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 58,
      "timestamp": "2026-01-10T19:44:18.275788"
    },
    {
      "sample_idx": 59,
      "input": "16/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies a parameningeal mass with intracranial extension and confirms Embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a parameningeal mass with intracranial extension and confirms Embryonal rhabdomyosarcoma on biopsy, indicating malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 59,
      "timestamp": "2026-01-10T19:44:18.275799"
    },
    {
      "sample_idx": 60,
      "input": "08/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, no abnormal enhancement, and no malignancy were identified on the brain MRI. The report concludes with 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no mass lesion, no abnormal enhancement, and no malignancy were identified on the brain MRI. The report concludes with 'No malignancy identified'.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 60,
      "timestamp": "2026-01-10T19:44:18.275810"
    },
    {
      "sample_idx": 61,
      "input": "09/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\"],\n        \"rationale\": \"The report describes abnormal findings related to a post-viral infection (lymphocytosis, atypical lymphocytes), but explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes abnormal findings related to a post-viral infection (lymphocytosis, atypical lymphocytes), but explicitly states 'No malignancy identified'.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving"
      ],
      "fracture_mentioned": null,
      "idx": 61,
      "timestamp": "2026-01-10T19:44:18.275821"
    },
    {
      "sample_idx": 62,
      "input": "08/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy due to a viral infection and explicitly states no malignancy was identified. No atypical features were noted.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states reactive lymphadenopathy due to a viral infection and explicitly states no malignancy was identified. No atypical features were noted.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 62,
      "timestamp": "2026-01-10T19:44:18.275833"
    },
    {
      "sample_idx": 63,
      "input": "04/12/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that blood counts have normalized, there is no organomegaly, and no malignancy was identified. The patient showed clinical improvement after a resolved febrile illness.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that blood counts have normalized, there is no organomegaly, and no malignancy was identified. The patient showed clinical improvement after a resolved febrile illness.",
      "findings": [
        "Resolved febrile illness",
        "Blood counts normalized",
        "No organomegaly",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 63,
      "timestamp": "2026-01-10T19:44:18.275845"
    },
    {
      "sample_idx": 64,
      "input": "29/09/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 29/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is an abnormal finding but explicitly states it is secondary to a viral infection and not malignancy. The decreasing node size further supports a benign process.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is an abnormal finding but explicitly states it is secondary to a viral infection and not malignancy. The decreasing node size further supports a benign process.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up"
      ],
      "fracture_mentioned": null,
      "idx": 64,
      "timestamp": "2026-01-10T19:44:18.275857"
    },
    {
      "sample_idx": 65,
      "input": "09/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 09/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Retinoblastoma\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly identifies an intraocular mass consistent with Retinoblastoma, a malignancy. The presence of bilateral disease and a detected RB1 germline mutation further supports this diagnosis.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies an intraocular mass consistent with Retinoblastoma, a malignancy. The presence of bilateral disease and a detected RB1 germline mutation further supports this diagnosis.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Retinoblastoma",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 65,
      "timestamp": "2026-01-10T19:44:18.275888"
    },
    {
      "sample_idx": 66,
      "input": "16/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Neuroblastoma\"],\n        \"rationale\": \"The report explicitly identifies a large suprarenal mass with calcifications and MIBG avidity, along with elevated urinary catecholamines, and diagnoses Stage III Neuroblastoma, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a large suprarenal mass with calcifications and MIBG avidity, along with elevated urinary catecholamines, and diagnoses Stage III Neuroblastoma, confirming malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 66,
      "timestamp": "2026-01-10T19:44:18.275901"
    },
    {
      "sample_idx": 67,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states normal blood counts, absence of blast cells, and no malignancy identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states normal blood counts, absence of blast cells, and no malignancy identified.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 67,
      "timestamp": "2026-01-10T19:44:18.275911"
    },
    {
      "sample_idx": 68,
      "input": "27/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies a parameningeal mass with intracranial extension and confirms Embryonal rhabdomyosarcoma on biopsy, which is a malignant tumor.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a parameningeal mass with intracranial extension and confirms Embryonal rhabdomyosarcoma on biopsy, which is a malignant tumor.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 68,
      "timestamp": "2026-01-10T19:44:18.275923"
    },
    {
      "sample_idx": 69,
      "input": "16/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 16/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings on the chest radiograph.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings on the chest radiograph.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 69,
      "timestamp": "2026-01-10T19:44:18.275934"
    },
    {
      "sample_idx": 70,
      "input": "29/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 29/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly identifies an intraocular mass with calcifications, bilateral disease, a positive family history, and a detected RB1 germline mutation, all strongly indicative of Retinoblastoma, a malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies an intraocular mass with calcifications, bilateral disease, a positive family history, and a detected RB1 germline mutation, all strongly indicative of Retinoblastoma, a malignancy.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 70,
      "timestamp": "2026-01-10T19:44:18.275946"
    },
    {
      "sample_idx": 71,
      "input": "11/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly identifies mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, confirming malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 71,
      "timestamp": "2026-01-10T19:44:18.275959"
    },
    {
      "sample_idx": 72,
      "input": "13/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 13/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies a parameningeal mass with intracranial extension and confirms Embryonal rhabdomyosarcoma on biopsy, which is a malignant tumor.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a parameningeal mass with intracranial extension and confirms Embryonal rhabdomyosarcoma on biopsy, which is a malignant tumor.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 72,
      "timestamp": "2026-01-10T19:44:18.275971"
    },
    {
      "sample_idx": 73,
      "input": "03/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 03/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\"],\n        \"rationale\": \"The report explicitly states physiological splenomegaly, which is considered a benign finding, but it is still an abnormal finding. The report explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states physiological splenomegaly, which is considered a benign finding, but it is still an abnormal finding. The report explicitly states 'No malignancy identified'.",
      "findings": [
        "Physiological splenomegaly for age"
      ],
      "fracture_mentioned": null,
      "idx": 73,
      "timestamp": "2026-01-10T19:44:18.275982"
    },
    {
      "sample_idx": 74,
      "input": "11/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"Onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes permeative bone destruction, a large soft tissue mass, and an onion-skin periosteal reaction in the femur, which are highly suggestive of a malignant bone tumor. The positive EWSR1 fusion test confirms the diagnosis of Ewing Sarcoma, a malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes permeative bone destruction, a large soft tissue mass, and an onion-skin periosteal reaction in the femur, which are highly suggestive of a malignant bone tumor. The positive EWSR1 fusion test confirms the diagnosis of Ewing Sarcoma, a malignancy.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "Onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 74,
      "timestamp": "2026-01-10T19:44:18.275996"
    },
    {
      "sample_idx": 75,
      "input": "28/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 28/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. Although lymphadenopathy is an abnormal finding, the report explicitly states 'No malignancy identified' and attributes the finding to a viral infection.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is a benign finding. Although lymphadenopathy is an abnormal finding, the report explicitly states 'No malignancy identified' and attributes the finding to a viral infection.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up"
      ],
      "fracture_mentioned": null,
      "idx": 75,
      "timestamp": "2026-01-10T19:44:18.276008"
    },
    {
      "sample_idx": 76,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states normal CBC with age-appropriate values, absence of blast cells, and explicitly states no malignancy identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states normal CBC with age-appropriate values, absence of blast cells, and explicitly states no malignancy identified.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 76,
      "timestamp": "2026-01-10T19:44:18.276019"
    },
    {
      "sample_idx": 77,
      "input": "06/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified, indicating normal findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there are no pathological features and no malignancy identified, indicating normal findings.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 77,
      "timestamp": "2026-01-10T19:44:18.276030"
    },
    {
      "sample_idx": 78,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"Acute Lymphoblastic Leukemia\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "Acute Lymphoblastic Leukemia"
      ],
      "fracture_mentioned": null,
      "idx": 78,
      "timestamp": "2026-01-10T19:44:18.276043"
    },
    {
      "sample_idx": 79,
      "input": "17/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 17/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are abnormal findings. However, the report explicitly states 'No malignancy identified' and confirms the findings are related to EBV infection (Monospot positive, EBV serology confirms).\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are abnormal findings. However, the report explicitly states 'No malignancy identified' and confirms the findings are related to EBV infection (Monospot positive, EBV serology confirms).",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 79,
      "timestamp": "2026-01-10T19:44:18.276056"
    },
    {
      "sample_idx": 80,
      "input": "18/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 18/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign presentation\", \"No focal lesions\", \"No malignancy identified\", \"Benign finding\"],\n        \"rationale\": \"The report explicitly states a benign presentation, no focal lesions, and no malignancy identified. Physiological splenomegaly is noted as a benign finding.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states a benign presentation, no focal lesions, and no malignancy identified. Physiological splenomegaly is noted as a benign finding.",
      "findings": [
        "Benign presentation",
        "No focal lesions",
        "No malignancy identified",
        "Benign finding"
      ],
      "fracture_mentioned": null,
      "idx": 80,
      "timestamp": "2026-01-10T19:44:18.276068"
    },
    {
      "sample_idx": 81,
      "input": "11/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\"],\n        \"rationale\": \"The report identifies a benign soft tissue mass, specifically a lipoma. While this is an abnormal finding, it is explicitly stated as benign and no malignancy was identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies a benign soft tissue mass, specifically a lipoma. While this is an abnormal finding, it is explicitly stated as benign and no malignancy was identified.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed"
      ],
      "fracture_mentioned": null,
      "idx": 81,
      "timestamp": "2026-01-10T19:44:18.276078"
    },
    {
      "sample_idx": 82,
      "input": "27/12/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 27/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly identifies a 'large heterogeneous left renal mass' and diagnoses 'Wilms Tumor', which is a malignant renal tumor in children. The biopsy confirms favorable histology, and it is staged as Stage II, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a 'large heterogeneous left renal mass' and diagnoses 'Wilms Tumor', which is a malignant renal tumor in children. The biopsy confirms favorable histology, and it is staged as Stage II, indicating malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 82,
      "timestamp": "2026-01-10T19:44:18.276091"
    },
    {
      "sample_idx": 83,
      "input": "05/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"Suspected Osteosarcoma\", \"Osteosarcoma\"],\n        \"rationale\": \"The report describes a destructive bone lesion with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. The clinical notes explicitly suspect and mention Osteosarcoma, a type of bone cancer.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive bone lesion with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. The clinical notes explicitly suspect and mention Osteosarcoma, a type of bone cancer.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "Suspected Osteosarcoma",
        "Osteosarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 83,
      "timestamp": "2026-01-10T19:44:18.276104"
    },
    {
      "sample_idx": 84,
      "input": "23/11/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 23/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No pathological features' and 'No malignancy identified'. The finding of a 'Healing fracture - normal process' is not pathological.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No pathological features' and 'No malignancy identified'. The finding of a 'Healing fracture - normal process' is not pathological.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 84,
      "timestamp": "2026-01-10T19:44:18.276116"
    },
    {
      "sample_idx": 85,
      "input": "14/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 14/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings in the chest radiograph, including clear lung fields and normal heart size.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings in the chest radiograph, including clear lung fields and normal heart size.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 85,
      "timestamp": "2026-01-10T19:44:18.276128"
    },
    {
      "sample_idx": 86,
      "input": "11/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Hepatoblastoma\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report explicitly identifies a 'large heterogeneous hepatic mass' and diagnoses 'Hepatoblastoma', which is a malignant liver tumor. Elevated AFP and staging (PRETEXT stage II) further support the presence of malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a 'large heterogeneous hepatic mass' and diagnoses 'Hepatoblastoma', which is a malignant liver tumor. Elevated AFP and staging (PRETEXT stage II) further support the presence of malignancy.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Hepatoblastoma",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 86,
      "timestamp": "2026-01-10T19:44:18.276141"
    },
    {
      "sample_idx": 87,
      "input": "16/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 16/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report explicitly identifies a high percentage of myeloblasts (70%) in the bone marrow and a specific chromosomal translocation (t(8;21)), both strongly indicative of Acute Myeloid Leukemia, a malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a high percentage of myeloblasts (70%) in the bone marrow and a specific chromosomal translocation (t(8;21)), both strongly indicative of Acute Myeloid Leukemia, a malignancy.",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 87,
      "timestamp": "2026-01-10T19:44:18.276153"
    },
    {
      "sample_idx": 88,
      "input": "29/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 29/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly identifies a Wilms Tumor, a type of kidney cancer, which is a malignancy. The report also describes the tumor characteristics (large heterogeneous left renal mass with pseudocapsule) and staging (Stage II), confirming the presence of malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a Wilms Tumor, a type of kidney cancer, which is a malignancy. The report also describes the tumor characteristics (large heterogeneous left renal mass with pseudocapsule) and staging (Stage II), confirming the presence of malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 88,
      "timestamp": "2026-01-10T19:44:18.276166"
    },
    {
      "sample_idx": 89,
      "input": "16/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with B-cell ALL, confirming malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 89,
      "timestamp": "2026-01-10T19:44:18.276178"
    },
    {
      "sample_idx": 90,
      "input": "06/09/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly identifies an intraocular mass with calcifications, bilateral disease, a positive family history, and a detected RB1 germline mutation, consistent with Retinoblastoma, a malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies an intraocular mass with calcifications, bilateral disease, a positive family history, and a detected RB1 germline mutation, consistent with Retinoblastoma, a malignancy.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 90,
      "timestamp": "2026-01-10T19:44:18.276191"
    },
    {
      "sample_idx": 91,
      "input": "30/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 30/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features were found and no malignancy was identified, indicating normal findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no pathological features were found and no malignancy was identified, indicating normal findings.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 91,
      "timestamp": "2026-01-10T19:44:18.276203"
    },
    {
      "sample_idx": 92,
      "input": "22/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 22/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes resolved benign findings with no aggressive features. There are no findings suggestive of malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes resolved benign findings with no aggressive features. There are no findings suggestive of malignancy.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence on imaging",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 92,
      "timestamp": "2026-01-10T19:44:18.276216"
    },
    {
      "sample_idx": 93,
      "input": "04/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 04/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No pathological features' and 'No malignancy identified' in the context of a healing fracture, which is described as a 'normal process'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No pathological features' and 'No malignancy identified' in the context of a healing fracture, which is described as a 'normal process'.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 93,
      "timestamp": "2026-01-10T19:44:18.276228"
    },
    {
      "sample_idx": 94,
      "input": "05/08/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'Normal brain MRI for age', 'No mass lesion', 'No abnormal enhancement', and concludes with 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'Normal brain MRI for age', 'No mass lesion', 'No abnormal enhancement', and concludes with 'No malignancy identified'.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 94,
      "timestamp": "2026-01-10T19:44:18.276239"
    },
    {
      "sample_idx": 95,
      "input": "10/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 10/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"Bone density normal\", \"Trauma history consistent\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No pathological features' and 'No malignancy identified' in the context of a healing fracture, which is described as a normal process. The report concludes with reassurance.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No pathological features' and 'No malignancy identified' in the context of a healing fracture, which is described as a normal process. The report concludes with reassurance.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "Bone density normal",
        "Trauma history consistent",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 95,
      "timestamp": "2026-01-10T19:44:18.276251"
    },
    {
      "sample_idx": 96,
      "input": "28/09/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 28/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly identifies a mediastinal mass, FDG-avid nodes, and diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a mediastinal mass, FDG-avid nodes, and diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, confirming malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 96,
      "timestamp": "2026-01-10T19:44:18.276263"
    },
    {
      "sample_idx": 97,
      "input": "02/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Glioma.\n\nFrom clinical notes: Brain Tumor - Glioma. Paediatric oncology assessment.\n\nFindings: left temporal lobe infiltrative mass with mass effect. FLAIR hyperintensity. Biopsy confirms diffuse astrocytoma WHO grade II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report explicitly identifies an infiltrative mass in the brain with biopsy confirmation of diffuse astrocytoma, which is a type of brain tumor (malignancy).\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies an infiltrative mass in the brain with biopsy confirmation of diffuse astrocytoma, which is a type of brain tumor (malignancy).",
      "findings": [
        "left temporal lobe infiltrative mass with mass effect",
        "FLAIR hyperintensity",
        "Biopsy confirms diffuse astrocytoma WHO grade II"
      ],
      "fracture_mentioned": null,
      "idx": 97,
      "timestamp": "2026-01-10T19:44:18.276275"
    },
    {
      "sample_idx": 98,
      "input": "29/06/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 29/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states normal blood counts, absence of blast cells, and confirms no malignancy was identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states normal blood counts, absence of blast cells, and confirms no malignancy was identified.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 98,
      "timestamp": "2026-01-10T19:44:18.276285"
    },
    {
      "sample_idx": 99,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, a bulky mass, and FDG-avid nodes, which are abnormal findings. The diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type, explicitly confirms malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes mediastinal lymphadenopathy, a bulky mass, and FDG-avid nodes, which are abnormal findings. The diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type, explicitly confirms malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 99,
      "timestamp": "2026-01-10T19:44:18.276298"
    }
  ],
  "num_samples": 100,
  "samples": [
    {
      "sample_idx": 0,
      "input": "02/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"Clinical improvement noted\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normalized blood counts and clinical improvement, indicating no current abnormal or malignant findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normalized blood counts and clinical improvement, indicating no current abnormal or malignant findings.",
      "findings": [
        "Resolved febrile illness",
        "Blood counts normalized",
        "No organomegaly",
        "Clinical improvement noted",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 0,
      "timestamp": "2026-01-10T19:44:18.275036"
    },
    {
      "sample_idx": 1,
      "input": "26/10/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly describes a posterior fossa mass with enhancement, restricted diffusion, and confirms high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes a posterior fossa mass with enhancement, restricted diffusion, and confirms high-grade medulloblastoma on histology, indicating malignancy.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 1,
      "timestamp": "2026-01-10T19:44:18.275063"
    },
    {
      "sample_idx": 2,
      "input": "03/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\"],\n        \"rationale\": \"The report identifies reactive lymphadenopathy, a benign finding. It explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies reactive lymphadenopathy, a benign finding. It explicitly states 'No malignancy identified'.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up"
      ],
      "fracture_mentioned": null,
      "idx": 2,
      "timestamp": "2026-01-10T19:44:18.275077"
    },
    {
      "sample_idx": 3,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy with mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"The report explicitly identifies abdominal lymphadenopathy and confirms Burkitt lymphoma via biopsy, which is a malignancy. High LDH levels are also noted, often associated with lymphoma.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies abdominal lymphadenopathy and confirms Burkitt lymphoma via biopsy, which is a malignancy. High LDH levels are also noted, often associated with lymphoma.",
      "findings": [
        "abdominal lymphadenopathy with mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "High LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 3,
      "timestamp": "2026-01-10T19:44:18.275091"
    },
    {
      "sample_idx": 4,
      "input": "04/05/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 04/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 4,
      "timestamp": "2026-01-10T19:44:18.275104"
    },
    {
      "sample_idx": 5,
      "input": "17/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 17/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is explicitly stated as secondary to a viral infection and not malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is explicitly stated as secondary to a viral infection and not malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection"
      ],
      "fracture_mentioned": null,
      "idx": 5,
      "timestamp": "2026-01-10T19:44:18.275116"
    },
    {
      "sample_idx": 6,
      "input": "11/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with the clinical suspicion and diagnosis of Neuroblastoma, a malignant tumour. The staging as Stage III disease further confirms malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines, consistent with the clinical suspicion and diagnosis of Neuroblastoma, a malignant tumour. The staging as Stage III disease further confirms malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 6,
      "timestamp": "2026-01-10T19:44:18.275132"
    },
    {
      "sample_idx": 7,
      "input": "21/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings on chest radiograph, including clear lung fields, no mediastinal mass, and normal heart size.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings on chest radiograph, including clear lung fields, no mediastinal mass, and normal heart size.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 7,
      "timestamp": "2026-01-10T19:44:18.275155"
    },
    {
      "sample_idx": 8,
      "input": "08/02/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states normal CBC values, absence of blast cells, and explicitly concludes 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states normal CBC values, absence of blast cells, and explicitly concludes 'No malignancy identified'.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 8,
      "timestamp": "2026-01-10T19:44:18.275168"
    },
    {
      "sample_idx": 9,
      "input": "25/04/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly describes a large left renal mass identified as a Wilms Tumor, which is a type of kidney cancer, and confirms its stage and histology, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes a large left renal mass identified as a Wilms Tumor, which is a type of kidney cancer, and confirms its stage and histology, indicating malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 9,
      "timestamp": "2026-01-10T19:44:18.275181"
    },
    {
      "sample_idx": 10,
      "input": "26/12/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy with bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly identifies mediastinal lymphadenopathy, FDG-avid nodes, and diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies mediastinal lymphadenopathy, FDG-avid nodes, and diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, confirming malignancy.",
      "findings": [
        "mediastinal lymphadenopathy with bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 10,
      "timestamp": "2026-01-10T19:44:18.275193"
    },
    {
      "sample_idx": 11,
      "input": "18/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 18/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications and MIBG avidity, along with elevated urinary catecholamines. These findings, combined with the clinical suspicion and diagnosis of Neuroblastoma, indicate malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large suprarenal mass with calcifications and MIBG avidity, along with elevated urinary catecholamines. These findings, combined with the clinical suspicion and diagnosis of Neuroblastoma, indicate malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 11,
      "timestamp": "2026-01-10T19:44:18.275208"
    },
    {
      "sample_idx": 12,
      "input": "15/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 15/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"Hepatoblastoma\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report explicitly identifies a large heterogeneous hepatic mass and diagnoses Hepatoblastoma, a malignant liver tumor, with a specific staging (PRETEXT stage II).\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a large heterogeneous hepatic mass and diagnoses Hepatoblastoma, a malignant liver tumor, with a specific staging (PRETEXT stage II).",
      "findings": [
        "large heterogeneous hepatic mass",
        "Hepatoblastoma",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 12,
      "timestamp": "2026-01-10T19:44:18.275219"
    },
    {
      "sample_idx": 13,
      "input": "26/02/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Langerhans Cell Histiocytosis.\n\nFrom clinical notes: Langerhans Cell Histiocytosis. Paediatric oncology assessment.\n\nFindings: multiple lytic skull lesions with soft tissue component. CD1a and Langerin positive. Multisystem disease. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\", \"Multisystem disease\"],\n        \"rationale\": \"The report describes multiple lytic skull lesions with soft tissue components, which are abnormal findings. The positive CD1a and Langerin markers, along with the description of multisystem disease, are characteristic features of Langerhans Cell Histiocytosis, a type of malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes multiple lytic skull lesions with soft tissue components, which are abnormal findings. The positive CD1a and Langerin markers, along with the description of multisystem disease, are characteristic features of Langerhans Cell Histiocytosis, a type of malignancy.",
      "findings": [
        "multiple lytic skull lesions with soft tissue component",
        "CD1a and Langerin positive",
        "Multisystem disease"
      ],
      "fracture_mentioned": null,
      "idx": 13,
      "timestamp": "2026-01-10T19:44:18.275233"
    },
    {
      "sample_idx": 14,
      "input": "08/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 08/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are abnormal findings but explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are abnormal findings but explicitly states 'No malignancy identified'.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 14,
      "timestamp": "2026-01-10T19:44:18.275245"
    },
    {
      "sample_idx": 15,
      "input": "14/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 14/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report explicitly identifies a high percentage of myeloblasts in the bone marrow and a specific chromosomal translocation (t(8;21)), both strongly indicative of Acute Myeloid Leukemia, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a high percentage of myeloblasts in the bone marrow and a specific chromosomal translocation (t(8;21)), both strongly indicative of Acute Myeloid Leukemia, confirming malignancy.",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 15,
      "timestamp": "2026-01-10T19:44:18.275257"
    },
    {
      "sample_idx": 16,
      "input": "07/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 07/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies a parameningeal mass with intracranial extension and confirms the diagnosis of Embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a parameningeal mass with intracranial extension and confirms the diagnosis of Embryonal rhabdomyosarcoma on biopsy, indicating malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 16,
      "timestamp": "2026-01-10T19:44:18.275269"
    },
    {
      "sample_idx": 17,
      "input": "06/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings on the chest radiograph.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings on the chest radiograph.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 17,
      "timestamp": "2026-01-10T19:44:18.275280"
    },
    {
      "sample_idx": 18,
      "input": "23/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 23/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report describes a posterior fossa mass with enhancement, hydrocephalus, and restricted diffusion. Histology confirms a high-grade medulloblastoma, which is a malignant brain tumor.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a posterior fossa mass with enhancement, hydrocephalus, and restricted diffusion. Histology confirms a high-grade medulloblastoma, which is a malignant brain tumor.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 18,
      "timestamp": "2026-01-10T19:44:18.275292"
    },
    {
      "sample_idx": 19,
      "input": "09/07/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Suspected Neuroblastoma\", \"Neuroblastoma\"],\n        \"rationale\": \"The report explicitly identifies a large suprarenal mass with characteristics (heterogeneous, calcifications, MIBG avidity) and associated findings (elevated urinary catecholamines) consistent with Neuroblastoma, which is a malignancy. The report also explicitly states the clinical suspicion and diagnosis of Neuroblastoma and assigns a stage (Stage III), indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a large suprarenal mass with characteristics (heterogeneous, calcifications, MIBG avidity) and associated findings (elevated urinary catecholamines) consistent with Neuroblastoma, which is a malignancy. The report also explicitly states the clinical suspicion and diagnosis of Neuroblastoma and assigns a stage (Stage III), indicating malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Suspected Neuroblastoma",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 19,
      "timestamp": "2026-01-10T19:44:18.275309"
    },
    {
      "sample_idx": 20,
      "input": "18/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly identifies a 'large heterogeneous left renal mass with pseudocapsule' and diagnoses 'Wilms Tumor', which is a type of kidney cancer, confirming malignancy. The biopsy showing 'Favorable histology' and staging as 'Stage II' further support this diagnosis.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a 'large heterogeneous left renal mass with pseudocapsule' and diagnoses 'Wilms Tumor', which is a type of kidney cancer, confirming malignancy. The biopsy showing 'Favorable histology' and staging as 'Stage II' further support this diagnosis.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 20,
      "timestamp": "2026-01-10T19:44:18.275323"
    },
    {
      "sample_idx": 21,
      "input": "13/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 13/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal for age, with no mass lesions or abnormal enhancement. It explicitly concludes 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the brain MRI is normal for age, with no mass lesions or abnormal enhancement. It explicitly concludes 'No malignancy identified'.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 21,
      "timestamp": "2026-01-10T19:44:18.275335"
    },
    {
      "sample_idx": 22,
      "input": "18/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly identifies a large heterogeneous left renal mass and diagnoses it as a Wilms Tumor, which is a type of kidney cancer. The biopsy confirms favorable histology, and it is staged as Stage II, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a large heterogeneous left renal mass and diagnoses it as a Wilms Tumor, which is a type of kidney cancer. The biopsy confirms favorable histology, and it is staged as Stage II, indicating malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 22,
      "timestamp": "2026-01-10T19:44:18.275349"
    },
    {
      "sample_idx": 23,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'Normal brain MRI for age', 'No mass lesion', 'No abnormal enhancement', and directly concludes 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'Normal brain MRI for age', 'No mass lesion', 'No abnormal enhancement', and directly concludes 'No malignancy identified'.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 23,
      "timestamp": "2026-01-10T19:44:18.275360"
    },
    {
      "sample_idx": 24,
      "input": "16/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings on the brain MRI.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings on the brain MRI.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 24,
      "timestamp": "2026-01-10T19:44:18.275372"
    },
    {
      "sample_idx": 25,
      "input": "16/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction\", \"large soft tissue mass\", \"Onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes findings characteristic of a malignant bone tumor, including permeative bone destruction, a large soft tissue mass, and an onion-skin periosteal reaction. The presence of an EWSR1 fusion gene is specific for Ewing Sarcoma, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes findings characteristic of a malignant bone tumor, including permeative bone destruction, a large soft tissue mass, and an onion-skin periosteal reaction. The presence of an EWSR1 fusion gene is specific for Ewing Sarcoma, confirming malignancy.",
      "findings": [
        "permeative bone destruction",
        "large soft tissue mass",
        "Onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 25,
      "timestamp": "2026-01-10T19:44:18.275386"
    },
    {
      "sample_idx": 26,
      "input": "13/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 13/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"The report explicitly identifies abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and confirms Burkitt lymphoma via biopsy, which is a malignancy. High LDH levels are also noted.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies abdominal lymphadenopathy, mesenteric and retroperitoneal nodes, and confirms Burkitt lymphoma via biopsy, which is a malignancy. High LDH levels are also noted.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "High LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 26,
      "timestamp": "2026-01-10T19:44:18.275399"
    },
    {
      "sample_idx": 27,
      "input": "25/06/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"Bone density normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes the findings as a 'normal process' with no pathological features.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes the findings as a 'normal process' with no pathological features.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "Bone density normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 27,
      "timestamp": "2026-01-10T19:44:18.275410"
    },
    {
      "sample_idx": 28,
      "input": "01/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 01/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified and notes the resolution of a benign bone cyst with no aggressive features.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified and notes the resolution of a benign bone cyst with no aggressive features.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 28,
      "timestamp": "2026-01-10T19:44:18.275421"
    },
    {
      "sample_idx": 29,
      "input": "04/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large heterogeneous suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and classifies the disease as Stage III. These findings are consistent with the suspected diagnosis of Neuroblastoma, a malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a large heterogeneous suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and classifies the disease as Stage III. These findings are consistent with the suspected diagnosis of Neuroblastoma, a malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 29,
      "timestamp": "2026-01-10T19:44:18.275434"
    },
    {
      "sample_idx": 30,
      "input": "15/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 15/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement\", \"hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"The report explicitly identifies a posterior fossa mass with enhancement, hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma on histology, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a posterior fossa mass with enhancement, hydrocephalus, restricted diffusion, and confirms high-grade medulloblastoma on histology, indicating malignancy.",
      "findings": [
        "posterior fossa mass with enhancement",
        "hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 30,
      "timestamp": "2026-01-10T19:44:18.275447"
    },
    {
      "sample_idx": 31,
      "input": "02/04/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'Normal chest radiograph', 'Clear lung fields', 'No mediastinal mass', and 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'Normal chest radiograph', 'Clear lung fields', 'No mediastinal mass', and 'No malignancy identified'.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 31,
      "timestamp": "2026-01-10T19:44:18.275458"
    },
    {
      "sample_idx": 32,
      "input": "04/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"The report explicitly identifies a sacrococcygeal mass with solid and cystic components, elevated tumor markers (AFP and beta-hCG), and the presence of yolk sac tumor elements, which is a type of malignant germ cell tumor.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a sacrococcygeal mass with solid and cystic components, elevated tumor markers (AFP and beta-hCG), and the presence of yolk sac tumor elements, which is a type of malignant germ cell tumor.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 32,
      "timestamp": "2026-01-10T19:44:18.275471"
    },
    {
      "sample_idx": 33,
      "input": "24/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and specifically diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, which is a malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and specifically diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, which is a malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 33,
      "timestamp": "2026-01-10T19:44:18.275484"
    },
    {
      "sample_idx": 34,
      "input": "07/03/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 07/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states normal CBC, absence of blast cells, and no malignancy identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states normal CBC, absence of blast cells, and no malignancy identified.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 34,
      "timestamp": "2026-01-10T19:44:18.275494"
    },
    {
      "sample_idx": 35,
      "input": "04/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\"],\n        \"rationale\": \"The report identifies a benign soft tissue mass confirmed as a lipoma, which is not a malignancy. The report explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies a benign soft tissue mass confirmed as a lipoma, which is not a malignancy. The report explicitly states 'No malignancy identified'.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement"
      ],
      "fracture_mentioned": null,
      "idx": 35,
      "timestamp": "2026-01-10T19:44:18.275506"
    },
    {
      "sample_idx": 36,
      "input": "04/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings on the chest radiograph.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings on the chest radiograph.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 36,
      "timestamp": "2026-01-10T19:44:18.275517"
    },
    {
      "sample_idx": 37,
      "input": "02/04/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"Suspected Osteosarcoma\", \"Osteosarcoma\"],\n        \"rationale\": \"The report describes a destructive lesion in the distal femur with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. The clinical notes explicitly mention suspicion and diagnosis of osteosarcoma, a malignant bone tumor.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the distal femur with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. The clinical notes explicitly mention suspicion and diagnosis of osteosarcoma, a malignant bone tumor.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "Suspected Osteosarcoma",
        "Osteosarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 37,
      "timestamp": "2026-01-10T19:44:18.275531"
    },
    {
      "sample_idx": 38,
      "input": "05/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 05/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"suspected Osteosarcoma\", \"Osteosarcoma\"],\n        \"rationale\": \"The report describes a destructive lesion in the femur with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. The clinical suspicion and diagnosis mentioned in the report strongly indicate malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive lesion in the femur with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. The clinical suspicion and diagnosis mentioned in the report strongly indicate malignancy.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "suspected Osteosarcoma",
        "Osteosarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 38,
      "timestamp": "2026-01-10T19:44:18.275544"
    },
    {
      "sample_idx": 39,
      "input": "01/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 01/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\"],\n        \"rationale\": \"The report describes abnormal findings related to a recent viral infection (post-viral lymphocytosis, resolving atypical lymphocytes), but explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes abnormal findings related to a recent viral infection (post-viral lymphocytosis, resolving atypical lymphocytes), but explicitly states 'No malignancy identified'.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving"
      ],
      "fracture_mentioned": null,
      "idx": 39,
      "timestamp": "2026-01-10T19:44:18.275555"
    },
    {
      "sample_idx": 40,
      "input": "26/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly identifies a 'large heterogeneous left renal mass' diagnosed as 'Wilms Tumor' with 'Favorable histology' and staging, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a 'large heterogeneous left renal mass' diagnosed as 'Wilms Tumor' with 'Favorable histology' and staging, indicating malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 40,
      "timestamp": "2026-01-10T19:44:18.275567"
    },
    {
      "sample_idx": 41,
      "input": "18/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly identifies mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, which are indicative of malignancy. The report also explicitly states the diagnosis as Classical Hodgkin, nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, which are indicative of malignancy. The report also explicitly states the diagnosis as Classical Hodgkin, nodular sclerosing type, confirming malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 41,
      "timestamp": "2026-01-10T19:44:18.275581"
    },
    {
      "sample_idx": 42,
      "input": "20/04/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 20/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report identifies abnormal findings related to a viral infection (post-viral lymphocytosis, atypical lymphocytes, positive Monospot, confirmed EBV). However, the report explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies abnormal findings related to a viral infection (post-viral lymphocytosis, atypical lymphocytes, positive Monospot, confirmed EBV). However, the report explicitly states 'No malignancy identified'.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 42,
      "timestamp": "2026-01-10T19:44:18.275594"
    },
    {
      "sample_idx": 43,
      "input": "20/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 20/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings on the brain MRI.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings on the brain MRI.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 43,
      "timestamp": "2026-01-10T19:44:18.275604"
    },
    {
      "sample_idx": 44,
      "input": "22/11/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 22/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"Onion-skin periosteal reaction\", \"EWSR1 fusion positive\", \"Suspected Ewing Sarcoma\", \"Ewing Sarcoma\"],\n        \"rationale\": \"The report describes permeative bone destruction, a large soft tissue mass, and an onion-skin periosteal reaction in the femur, which are characteristic imaging findings of Ewing Sarcoma. Additionally, the EWSR1 fusion positivity is a specific genetic marker for Ewing Sarcoma. The clinical suspicion and diagnosis of Ewing Sarcoma confirm malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes permeative bone destruction, a large soft tissue mass, and an onion-skin periosteal reaction in the femur, which are characteristic imaging findings of Ewing Sarcoma. Additionally, the EWSR1 fusion positivity is a specific genetic marker for Ewing Sarcoma. The clinical suspicion and diagnosis of Ewing Sarcoma confirm malignancy.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "Onion-skin periosteal reaction",
        "EWSR1 fusion positive",
        "Suspected Ewing Sarcoma",
        "Ewing Sarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 44,
      "timestamp": "2026-01-10T19:44:18.275620"
    },
    {
      "sample_idx": 45,
      "input": "06/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states a normal brain MRI for age, absence of mass lesions or abnormal enhancement, and directly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states a normal brain MRI for age, absence of mass lesions or abnormal enhancement, and directly states 'No malignancy identified'.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 45,
      "timestamp": "2026-01-10T19:44:18.275631"
    },
    {
      "sample_idx": 46,
      "input": "24/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\"],\n        \"rationale\": \"The report identifies physiological splenomegaly as an abnormal finding but explicitly states it is benign and no malignancy was identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies physiological splenomegaly as an abnormal finding but explicitly states it is benign and no malignancy was identified.",
      "findings": [
        "Physiological splenomegaly for age"
      ],
      "fracture_mentioned": null,
      "idx": 46,
      "timestamp": "2026-01-10T19:44:18.275641"
    },
    {
      "sample_idx": 47,
      "input": "01/02/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 01/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\"],\n        \"rationale\": \"The report explicitly describes reactive lymphadenopathy, which is a benign finding. It also notes decreasing node size and explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly describes reactive lymphadenopathy, which is a benign finding. It also notes decreasing node size and explicitly states 'No malignancy identified'.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up"
      ],
      "fracture_mentioned": null,
      "idx": 47,
      "timestamp": "2026-01-10T19:44:18.275653"
    },
    {
      "sample_idx": 48,
      "input": "03/10/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"suspected osteosarcoma\", \"osteosarcoma\"],\n        \"rationale\": \"The report describes a destructive bone lesion with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. Osteosarcoma is explicitly suspected and mentioned in the clinical notes.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive bone lesion with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. Osteosarcoma is explicitly suspected and mentioned in the clinical notes.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "suspected osteosarcoma",
        "osteosarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 48,
      "timestamp": "2026-01-10T19:44:18.275666"
    },
    {
      "sample_idx": 49,
      "input": "05/08/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\"],\n        \"rationale\": \"The report identifies reactive lymphadenopathy, which is explicitly stated as secondary to a viral infection and not malignancy. The decreasing node size further supports a benign process.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies reactive lymphadenopathy, which is explicitly stated as secondary to a viral infection and not malignancy. The decreasing node size further supports a benign process.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up"
      ],
      "fracture_mentioned": null,
      "idx": 49,
      "timestamp": "2026-01-10T19:44:18.275678"
    },
    {
      "sample_idx": 50,
      "input": "02/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings on chest radiograph.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings on chest radiograph.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 50,
      "timestamp": "2026-01-10T19:44:18.275689"
    },
    {
      "sample_idx": 51,
      "input": "26/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\", \"Well-circumscribed\", \"No enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes the finding as a 'Benign soft tissue mass - lipoma confirmed'. There are no findings suggestive of malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes the finding as a 'Benign soft tissue mass - lipoma confirmed'. There are no findings suggestive of malignancy.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed",
        "Well-circumscribed",
        "No enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 51,
      "timestamp": "2026-01-10T19:44:18.275701"
    },
    {
      "sample_idx": 52,
      "input": "25/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 25/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly identifies a large heterogeneous left renal mass, diagnosed as Wilms Tumor based on biopsy with favorable histology and staged as Stage II, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a large heterogeneous left renal mass, diagnosed as Wilms Tumor based on biopsy with favorable histology and staged as Stage II, confirming malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 52,
      "timestamp": "2026-01-10T19:44:18.275713"
    },
    {
      "sample_idx": 53,
      "input": "05/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is an abnormal finding but explicitly states it is secondary to a viral infection and not malignancy. The report explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is an abnormal finding but explicitly states it is secondary to a viral infection and not malignancy. The report explicitly states 'No malignancy identified'.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 53,
      "timestamp": "2026-01-10T19:44:18.275726"
    },
    {
      "sample_idx": 54,
      "input": "23/03/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 23/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Hepatoblastoma\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report explicitly identifies a 'large heterogeneous hepatic mass', 'elevated AFP', and diagnoses 'Hepatoblastoma' with a 'Fetal histology subtype' and 'PRETEXT stage II', confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a 'large heterogeneous hepatic mass', 'elevated AFP', and diagnoses 'Hepatoblastoma' with a 'Fetal histology subtype' and 'PRETEXT stage II', confirming malignancy.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Hepatoblastoma",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 54,
      "timestamp": "2026-01-10T19:44:18.275738"
    },
    {
      "sample_idx": 55,
      "input": "31/08/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 31/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'Normal chest radiograph', 'Clear lung fields', 'No mediastinal mass', 'Heart size normal', and directly concludes 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'Normal chest radiograph', 'Clear lung fields', 'No mediastinal mass', 'Heart size normal', and directly concludes 'No malignancy identified'.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 55,
      "timestamp": "2026-01-10T19:44:18.275750"
    },
    {
      "sample_idx": 56,
      "input": "26/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is an abnormal finding but explicitly states it is secondary to a viral infection and not malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is an abnormal finding but explicitly states it is secondary to a viral infection and not malignancy.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection"
      ],
      "fracture_mentioned": null,
      "idx": 56,
      "timestamp": "2026-01-10T19:44:18.275761"
    },
    {
      "sample_idx": 57,
      "input": "24/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"The report explicitly identifies a sacrococcygeal mass with solid and cystic components, elevated tumor markers (AFP and beta-hCG), and the presence of yolk sac tumor elements, which are indicative of malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a sacrococcygeal mass with solid and cystic components, elevated tumor markers (AFP and beta-hCG), and the presence of yolk sac tumor elements, which are indicative of malignancy.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 57,
      "timestamp": "2026-01-10T19:44:18.275774"
    },
    {
      "sample_idx": 58,
      "input": "01/01/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 01/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"Elevated AFP and beta-hCG\", \"Yolk sac tumor elements present\"],\n        \"rationale\": \"The report explicitly describes a sacrococcygeal mass with solid and cystic components, elevated tumor markers (AFP and beta-hCG), and the presence of yolk sac tumor elements, which are indicative of a malignant germ cell tumor.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly describes a sacrococcygeal mass with solid and cystic components, elevated tumor markers (AFP and beta-hCG), and the presence of yolk sac tumor elements, which are indicative of a malignant germ cell tumor.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "Elevated AFP and beta-hCG",
        "Yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 58,
      "timestamp": "2026-01-10T19:44:18.275788"
    },
    {
      "sample_idx": 59,
      "input": "16/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies a parameningeal mass with intracranial extension and confirms Embryonal rhabdomyosarcoma on biopsy, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a parameningeal mass with intracranial extension and confirms Embryonal rhabdomyosarcoma on biopsy, indicating malignancy.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 59,
      "timestamp": "2026-01-10T19:44:18.275799"
    },
    {
      "sample_idx": 60,
      "input": "08/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no mass lesion, no abnormal enhancement, and no malignancy were identified on the brain MRI. The report concludes with 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no mass lesion, no abnormal enhancement, and no malignancy were identified on the brain MRI. The report concludes with 'No malignancy identified'.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 60,
      "timestamp": "2026-01-10T19:44:18.275810"
    },
    {
      "sample_idx": 61,
      "input": "09/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\"],\n        \"rationale\": \"The report describes abnormal findings related to a post-viral infection (lymphocytosis, atypical lymphocytes), but explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes abnormal findings related to a post-viral infection (lymphocytosis, atypical lymphocytes), but explicitly states 'No malignancy identified'.",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving"
      ],
      "fracture_mentioned": null,
      "idx": 61,
      "timestamp": "2026-01-10T19:44:18.275821"
    },
    {
      "sample_idx": 62,
      "input": "08/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy due to a viral infection and explicitly states no malignancy was identified. No atypical features were noted.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states reactive lymphadenopathy due to a viral infection and explicitly states no malignancy was identified. No atypical features were noted.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 62,
      "timestamp": "2026-01-10T19:44:18.275833"
    },
    {
      "sample_idx": 63,
      "input": "04/12/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Resolved febrile illness\", \"Blood counts normalized\", \"No organomegaly\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that blood counts have normalized, there is no organomegaly, and no malignancy was identified. The patient showed clinical improvement after a resolved febrile illness.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that blood counts have normalized, there is no organomegaly, and no malignancy was identified. The patient showed clinical improvement after a resolved febrile illness.",
      "findings": [
        "Resolved febrile illness",
        "Blood counts normalized",
        "No organomegaly",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 63,
      "timestamp": "2026-01-10T19:44:18.275845"
    },
    {
      "sample_idx": 64,
      "input": "29/09/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 29/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is an abnormal finding but explicitly states it is secondary to a viral infection and not malignancy. The decreasing node size further supports a benign process.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is an abnormal finding but explicitly states it is secondary to a viral infection and not malignancy. The decreasing node size further supports a benign process.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up"
      ],
      "fracture_mentioned": null,
      "idx": 64,
      "timestamp": "2026-01-10T19:44:18.275857"
    },
    {
      "sample_idx": 65,
      "input": "09/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 09/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Retinoblastoma\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly identifies an intraocular mass consistent with Retinoblastoma, a malignancy. The presence of bilateral disease and a detected RB1 germline mutation further supports this diagnosis.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies an intraocular mass consistent with Retinoblastoma, a malignancy. The presence of bilateral disease and a detected RB1 germline mutation further supports this diagnosis.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Retinoblastoma",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 65,
      "timestamp": "2026-01-10T19:44:18.275888"
    },
    {
      "sample_idx": 66,
      "input": "16/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"Elevated urinary catecholamines\", \"Stage III disease\", \"Neuroblastoma\"],\n        \"rationale\": \"The report explicitly identifies a large suprarenal mass with calcifications and MIBG avidity, along with elevated urinary catecholamines, and diagnoses Stage III Neuroblastoma, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a large suprarenal mass with calcifications and MIBG avidity, along with elevated urinary catecholamines, and diagnoses Stage III Neuroblastoma, confirming malignancy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "Elevated urinary catecholamines",
        "Stage III disease",
        "Neuroblastoma"
      ],
      "fracture_mentioned": null,
      "idx": 66,
      "timestamp": "2026-01-10T19:44:18.275901"
    },
    {
      "sample_idx": 67,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states normal blood counts, absence of blast cells, and no malignancy identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states normal blood counts, absence of blast cells, and no malignancy identified.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 67,
      "timestamp": "2026-01-10T19:44:18.275911"
    },
    {
      "sample_idx": 68,
      "input": "27/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies a parameningeal mass with intracranial extension and confirms Embryonal rhabdomyosarcoma on biopsy, which is a malignant tumor.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a parameningeal mass with intracranial extension and confirms Embryonal rhabdomyosarcoma on biopsy, which is a malignant tumor.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 68,
      "timestamp": "2026-01-10T19:44:18.275923"
    },
    {
      "sample_idx": 69,
      "input": "16/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 16/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings on the chest radiograph.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings on the chest radiograph.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 69,
      "timestamp": "2026-01-10T19:44:18.275934"
    },
    {
      "sample_idx": 70,
      "input": "29/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 29/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly identifies an intraocular mass with calcifications, bilateral disease, a positive family history, and a detected RB1 germline mutation, all strongly indicative of Retinoblastoma, a malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies an intraocular mass with calcifications, bilateral disease, a positive family history, and a detected RB1 germline mutation, all strongly indicative of Retinoblastoma, a malignancy.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 70,
      "timestamp": "2026-01-10T19:44:18.275946"
    },
    {
      "sample_idx": 71,
      "input": "11/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly identifies mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies mediastinal lymphadenopathy, a bulky anterior mediastinal mass, FDG-avid nodes, and diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, confirming malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 71,
      "timestamp": "2026-01-10T19:44:18.275959"
    },
    {
      "sample_idx": 72,
      "input": "13/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 13/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"Embryonal rhabdomyosarcoma on biopsy\"],\n        \"rationale\": \"The report explicitly identifies a parameningeal mass with intracranial extension and confirms Embryonal rhabdomyosarcoma on biopsy, which is a malignant tumor.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a parameningeal mass with intracranial extension and confirms Embryonal rhabdomyosarcoma on biopsy, which is a malignant tumor.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "Embryonal rhabdomyosarcoma on biopsy"
      ],
      "fracture_mentioned": null,
      "idx": 72,
      "timestamp": "2026-01-10T19:44:18.275971"
    },
    {
      "sample_idx": 73,
      "input": "03/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 03/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Physiological splenomegaly for age\"],\n        \"rationale\": \"The report explicitly states physiological splenomegaly, which is considered a benign finding, but it is still an abnormal finding. The report explicitly states 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states physiological splenomegaly, which is considered a benign finding, but it is still an abnormal finding. The report explicitly states 'No malignancy identified'.",
      "findings": [
        "Physiological splenomegaly for age"
      ],
      "fracture_mentioned": null,
      "idx": 73,
      "timestamp": "2026-01-10T19:44:18.275982"
    },
    {
      "sample_idx": 74,
      "input": "11/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"Onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"The report describes permeative bone destruction, a large soft tissue mass, and an onion-skin periosteal reaction in the femur, which are highly suggestive of a malignant bone tumor. The positive EWSR1 fusion test confirms the diagnosis of Ewing Sarcoma, a malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes permeative bone destruction, a large soft tissue mass, and an onion-skin periosteal reaction in the femur, which are highly suggestive of a malignant bone tumor. The positive EWSR1 fusion test confirms the diagnosis of Ewing Sarcoma, a malignancy.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "Onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 74,
      "timestamp": "2026-01-10T19:44:18.275996"
    },
    {
      "sample_idx": 75,
      "input": "28/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 28/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\"],\n        \"rationale\": \"The report describes reactive lymphadenopathy, which is a benign finding. Although lymphadenopathy is an abnormal finding, the report explicitly states 'No malignancy identified' and attributes the finding to a viral infection.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes reactive lymphadenopathy, which is a benign finding. Although lymphadenopathy is an abnormal finding, the report explicitly states 'No malignancy identified' and attributes the finding to a viral infection.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up"
      ],
      "fracture_mentioned": null,
      "idx": 75,
      "timestamp": "2026-01-10T19:44:18.276008"
    },
    {
      "sample_idx": 76,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states normal CBC with age-appropriate values, absence of blast cells, and explicitly states no malignancy identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states normal CBC with age-appropriate values, absence of blast cells, and explicitly states no malignancy identified.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 76,
      "timestamp": "2026-01-10T19:44:18.276019"
    },
    {
      "sample_idx": 77,
      "input": "06/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified, indicating normal findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there are no pathological features and no malignancy identified, indicating normal findings.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 77,
      "timestamp": "2026-01-10T19:44:18.276030"
    },
    {
      "sample_idx": 78,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"Acute Lymphoblastic Leukemia\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with acute lymphoblastic leukemia, confirming malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "Acute Lymphoblastic Leukemia"
      ],
      "fracture_mentioned": null,
      "idx": 78,
      "timestamp": "2026-01-10T19:44:18.276043"
    },
    {
      "sample_idx": 79,
      "input": "17/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 17/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Post-viral lymphocytosis\", \"Atypical lymphocytes resolving\", \"Monospot positive\", \"EBV serology confirms\"],\n        \"rationale\": \"The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are abnormal findings. However, the report explicitly states 'No malignancy identified' and confirms the findings are related to EBV infection (Monospot positive, EBV serology confirms).\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report describes post-viral lymphocytosis and resolving atypical lymphocytes, which are abnormal findings. However, the report explicitly states 'No malignancy identified' and confirms the findings are related to EBV infection (Monospot positive, EBV serology confirms).",
      "findings": [
        "Post-viral lymphocytosis",
        "Atypical lymphocytes resolving",
        "Monospot positive",
        "EBV serology confirms"
      ],
      "fracture_mentioned": null,
      "idx": 79,
      "timestamp": "2026-01-10T19:44:18.276056"
    },
    {
      "sample_idx": 80,
      "input": "18/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 18/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign presentation\", \"No focal lesions\", \"No malignancy identified\", \"Benign finding\"],\n        \"rationale\": \"The report explicitly states a benign presentation, no focal lesions, and no malignancy identified. Physiological splenomegaly is noted as a benign finding.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states a benign presentation, no focal lesions, and no malignancy identified. Physiological splenomegaly is noted as a benign finding.",
      "findings": [
        "Benign presentation",
        "No focal lesions",
        "No malignancy identified",
        "Benign finding"
      ],
      "fracture_mentioned": null,
      "idx": 80,
      "timestamp": "2026-01-10T19:44:18.276068"
    },
    {
      "sample_idx": 81,
      "input": "11/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign soft tissue mass - lipoma confirmed\"],\n        \"rationale\": \"The report identifies a benign soft tissue mass, specifically a lipoma. While this is an abnormal finding, it is explicitly stated as benign and no malignancy was identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report identifies a benign soft tissue mass, specifically a lipoma. While this is an abnormal finding, it is explicitly stated as benign and no malignancy was identified.",
      "findings": [
        "Benign soft tissue mass - lipoma confirmed"
      ],
      "fracture_mentioned": null,
      "idx": 81,
      "timestamp": "2026-01-10T19:44:18.276078"
    },
    {
      "sample_idx": 82,
      "input": "27/12/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 27/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly identifies a 'large heterogeneous left renal mass' and diagnoses 'Wilms Tumor', which is a malignant renal tumor in children. The biopsy confirms favorable histology, and it is staged as Stage II, indicating malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a 'large heterogeneous left renal mass' and diagnoses 'Wilms Tumor', which is a malignant renal tumor in children. The biopsy confirms favorable histology, and it is staged as Stage II, indicating malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 82,
      "timestamp": "2026-01-10T19:44:18.276091"
    },
    {
      "sample_idx": 83,
      "input": "05/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"Sunburst periosteal reaction\", \"Suspected Osteosarcoma\", \"Osteosarcoma\"],\n        \"rationale\": \"The report describes a destructive bone lesion with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. The clinical notes explicitly suspect and mention Osteosarcoma, a type of bone cancer.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes a destructive bone lesion with a soft tissue component and a sunburst periosteal reaction, which are characteristic features of osteosarcoma. The clinical notes explicitly suspect and mention Osteosarcoma, a type of bone cancer.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "Sunburst periosteal reaction",
        "Suspected Osteosarcoma",
        "Osteosarcoma"
      ],
      "fracture_mentioned": null,
      "idx": 83,
      "timestamp": "2026-01-10T19:44:18.276104"
    },
    {
      "sample_idx": 84,
      "input": "23/11/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 23/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No pathological features' and 'No malignancy identified'. The finding of a 'Healing fracture - normal process' is not pathological.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No pathological features' and 'No malignancy identified'. The finding of a 'Healing fracture - normal process' is not pathological.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 84,
      "timestamp": "2026-01-10T19:44:18.276116"
    },
    {
      "sample_idx": 85,
      "input": "14/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 14/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Heart size normal\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes normal findings in the chest radiograph, including clear lung fields and normal heart size.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes normal findings in the chest radiograph, including clear lung fields and normal heart size.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Heart size normal",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 85,
      "timestamp": "2026-01-10T19:44:18.276128"
    },
    {
      "sample_idx": 86,
      "input": "11/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Hepatoblastoma\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"The report explicitly identifies a 'large heterogeneous hepatic mass' and diagnoses 'Hepatoblastoma', which is a malignant liver tumor. Elevated AFP and staging (PRETEXT stage II) further support the presence of malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a 'large heterogeneous hepatic mass' and diagnoses 'Hepatoblastoma', which is a malignant liver tumor. Elevated AFP and staging (PRETEXT stage II) further support the presence of malignancy.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Hepatoblastoma",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 86,
      "timestamp": "2026-01-10T19:44:18.276141"
    },
    {
      "sample_idx": 87,
      "input": "16/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 16/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"The report explicitly identifies a high percentage of myeloblasts (70%) in the bone marrow and a specific chromosomal translocation (t(8;21)), both strongly indicative of Acute Myeloid Leukemia, a malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a high percentage of myeloblasts (70%) in the bone marrow and a specific chromosomal translocation (t(8;21)), both strongly indicative of Acute Myeloid Leukemia, a malignancy.",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 87,
      "timestamp": "2026-01-10T19:44:18.276153"
    },
    {
      "sample_idx": 88,
      "input": "29/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 29/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"Wilms Tumor\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"The report explicitly identifies a Wilms Tumor, a type of kidney cancer, which is a malignancy. The report also describes the tumor characteristics (large heterogeneous left renal mass with pseudocapsule) and staging (Stage II), confirming the presence of malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a Wilms Tumor, a type of kidney cancer, which is a malignancy. The report also describes the tumor characteristics (large heterogeneous left renal mass with pseudocapsule) and staging (Stage II), confirming the presence of malignancy.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "Wilms Tumor",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 88,
      "timestamp": "2026-01-10T19:44:18.276166"
    },
    {
      "sample_idx": 89,
      "input": "16/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\"],\n        \"rationale\": \"The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with B-cell ALL, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies bone marrow infiltration with lymphoblasts and immunophenotyping consistent with B-cell ALL, confirming malignancy.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL"
      ],
      "fracture_mentioned": null,
      "idx": 89,
      "timestamp": "2026-01-10T19:44:18.276178"
    },
    {
      "sample_idx": 90,
      "input": "06/09/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"Bilateral disease\", \"Family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"The report explicitly identifies an intraocular mass with calcifications, bilateral disease, a positive family history, and a detected RB1 germline mutation, consistent with Retinoblastoma, a malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies an intraocular mass with calcifications, bilateral disease, a positive family history, and a detected RB1 germline mutation, consistent with Retinoblastoma, a malignancy.",
      "findings": [
        "intraocular mass with calcifications",
        "Bilateral disease",
        "Family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 90,
      "timestamp": "2026-01-10T19:44:18.276191"
    },
    {
      "sample_idx": 91,
      "input": "30/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 30/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no pathological features were found and no malignancy was identified, indicating normal findings.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no pathological features were found and no malignancy was identified, indicating normal findings.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 91,
      "timestamp": "2026-01-10T19:44:18.276203"
    },
    {
      "sample_idx": 92,
      "input": "22/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 22/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No malignancy identified' and describes resolved benign findings with no aggressive features. There are no findings suggestive of malignancy.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No malignancy identified' and describes resolved benign findings with no aggressive features. There are no findings suggestive of malignancy.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence on imaging",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 92,
      "timestamp": "2026-01-10T19:44:18.276216"
    },
    {
      "sample_idx": 93,
      "input": "04/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 04/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No pathological features' and 'No malignancy identified' in the context of a healing fracture, which is described as a 'normal process'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No pathological features' and 'No malignancy identified' in the context of a healing fracture, which is described as a 'normal process'.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 93,
      "timestamp": "2026-01-10T19:44:18.276228"
    },
    {
      "sample_idx": 94,
      "input": "05/08/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal brain MRI for age\", \"No mass lesion\", \"No abnormal enhancement\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'Normal brain MRI for age', 'No mass lesion', 'No abnormal enhancement', and concludes with 'No malignancy identified'.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'Normal brain MRI for age', 'No mass lesion', 'No abnormal enhancement', and concludes with 'No malignancy identified'.",
      "findings": [
        "Normal brain MRI for age",
        "No mass lesion",
        "No abnormal enhancement",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 94,
      "timestamp": "2026-01-10T19:44:18.276239"
    },
    {
      "sample_idx": 95,
      "input": "10/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 10/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Healing fracture - normal process\", \"No pathological features\", \"Bone density normal\", \"Trauma history consistent\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'No pathological features' and 'No malignancy identified' in the context of a healing fracture, which is described as a normal process. The report concludes with reassurance.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states 'No pathological features' and 'No malignancy identified' in the context of a healing fracture, which is described as a normal process. The report concludes with reassurance.",
      "findings": [
        "Healing fracture - normal process",
        "No pathological features",
        "Bone density normal",
        "Trauma history consistent",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 95,
      "timestamp": "2026-01-10T19:44:18.276251"
    },
    {
      "sample_idx": 96,
      "input": "28/09/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 28/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report explicitly identifies a mediastinal mass, FDG-avid nodes, and diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, confirming malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies a mediastinal mass, FDG-avid nodes, and diagnoses Classical Hodgkin Lymphoma, nodular sclerosing type, confirming malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 96,
      "timestamp": "2026-01-10T19:44:18.276263"
    },
    {
      "sample_idx": 97,
      "input": "02/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Glioma.\n\nFrom clinical notes: Brain Tumor - Glioma. Paediatric oncology assessment.\n\nFindings: left temporal lobe infiltrative mass with mass effect. FLAIR hyperintensity. Biopsy confirms diffuse astrocytoma WHO grade II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"Biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"The report explicitly identifies an infiltrative mass in the brain with biopsy confirmation of diffuse astrocytoma, which is a type of brain tumor (malignancy).\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report explicitly identifies an infiltrative mass in the brain with biopsy confirmation of diffuse astrocytoma, which is a type of brain tumor (malignancy).",
      "findings": [
        "left temporal lobe infiltrative mass with mass effect",
        "FLAIR hyperintensity",
        "Biopsy confirms diffuse astrocytoma WHO grade II"
      ],
      "fracture_mentioned": null,
      "idx": 97,
      "timestamp": "2026-01-10T19:44:18.276275"
    },
    {
      "sample_idx": 98,
      "input": "29/06/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 29/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC with age-appropriate values\", \"No blast cells\", \"No malignancy identified\"],\n        \"rationale\": \"The report explicitly states normal blood counts, absence of blast cells, and confirms no malignancy was identified.\"\n    }\n}\n```",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states normal blood counts, absence of blast cells, and confirms no malignancy was identified.",
      "findings": [
        "Normal CBC with age-appropriate values",
        "No blast cells",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 98,
      "timestamp": "2026-01-10T19:44:18.276285"
    },
    {
      "sample_idx": 99,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"The report describes mediastinal lymphadenopathy, a bulky mass, and FDG-avid nodes, which are abnormal findings. The diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type, explicitly confirms malignancy.\"\n    }\n}\n```",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "The report describes mediastinal lymphadenopathy, a bulky mass, and FDG-avid nodes, which are abnormal findings. The diagnosis of Classical Hodgkin Lymphoma, nodular sclerosing type, explicitly confirms malignancy.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 99,
      "timestamp": "2026-01-10T19:44:18.276298"
    }
  ],
  "end_time": "2026-01-10T19:44:18.276528",
  "duration_seconds": 71.138932
}